Latest News
The success of Forex trading comes down to timing, and understanding orders will help you fine-tune the execution process. The three main order types include market, limit, and stop orders, and you’re about to learn how they differ and how you can use them properly. These orders help you find the right time to enter [...]
Via Visibility · July 9, 2026
Information Services Group (NASDAQ:III) said technology demand continued to expand sharply in the second quarter, driven primarily by cloud-based software and infrastructure services tied to artificial intelligence, while traditional managed services remained in low-single-digit growth mode.
On its
Via MarketBeat · July 10, 2026
Delta Air Lines (NYSE:DAL) reported record June-quarter revenue and better-than-expected profitability, with executives telling analysts that strong demand, fare momentum and diversified revenue streams are supporting the carrier’s full-year outlook despite a sharp increase in fuel costs.
Chief Exe
Via MarketBeat · July 10, 2026
These companies sport recent dividend yields of 5.1%, 5.6%, and 6.6%.
Via The Motley Fool · July 10, 2026
A $100,000 portfolio doesn’t need huge gains to feel useful when dividends can create thousands in cash every year.
Via The Motley Fool · July 10, 2026
AeroVironment shares fell 38% after analyst downgrades on its 2030 targets, yet Q4 revenue hit $642 million with 22% EBITDA margins and a $2.7 billion backlog.
Via MarketBeat · July 10, 2026
The social media maven is making waves with its AI progress.
Via The Motley Fool · July 10, 2026
The chipmaker is maintaining its dominant market share and continues to achieve rapid revenue growth.
Via The Motley Fool · July 10, 2026
American Express is down by 10% this year, but second-quarter earnings can provide the exact catalyst it needs to stage a comeback.
Via The Motley Fool · July 10, 2026
Everyone's talking about SpaceX, but these two AI space stocks are up big in 2026.
Via The Motley Fool · July 10, 2026
Micron accelerated its $250 billion U.S. fabrication buildout, securing a domestic silicon supply deal with GlobalWafers as it races SK Hynix in the HBM4 memory market.
Via MarketBeat · July 10, 2026
Ark Invest is lightening its stake in three popular investments.
Via The Motley Fool · July 10, 2026
Vanguard's factor ETF lineup doesn't get a lot of attention. Its track record of market-beating returns suggests it should.
Via The Motley Fool · July 10, 2026
Check out the companies making headlines this week: Lazard (NYSE:LAZ): Financial advisory firm Lazard (NYSE:LAZ) rose by 4.4% on Thursday after it was announ...
Via StockStory · July 10, 2026
There's a moment almost every growing UK business hits: payroll stops being a quick monthly task and starts becoming a genuine liability. Maybe it's a miss
Via Talk Markets · July 10, 2026
Everyone is celebrating Broadcom's win, but it benefits Apple, too.
Via The Motley Fool · July 10, 2026
Needham raised nLIGHT's price target to $90 after the company secured a JLWS contract worth up to $627 million with future development and production opportunities.
Via Benzinga · July 10, 2026
Ahead of the SK Hynix Nasdaq debut, ETF issuers are rolling out leveraged funds to capitalize on demand for AI memory and single-stock ETFs.
Via Benzinga · July 10, 2026
Sadot Group (SDOT) stock drops sharply amid dilution worries from a $3.36M debt settlement and a scathing "uninvestable" short report.
Via Benzinga · July 10, 2026
Figma shares are trading lower Friday morning as traders weigh a recent bullish analyst view against a softer tape for growth software.
Via Benzinga · July 10, 2026
Bloom Energy stock has surged on data center power demand. Could FuelCell be the next big winner?
Via The Motley Fool · July 10, 2026
Rocket Lab stock is down 45% from its peak, but a record-fast Space Force launch, Morgan Stanley's $293 bull case, and the Iridium deal highlight bullish fundamentals ahead of Aug. 6 earnings.
Via MarketBeat · July 10, 2026
The private markets boom that thrived on abundant capital and rising valuations is giving way to a more demanding investment environment.
Via Benzinga · July 10, 2026
Ionis and AstraZeneca's Phase 3 ATTR-CM trial misses its primary goal, analyst says the outcome favors existing and next-gen therapies.
Via Benzinga · July 10, 2026
Telus (TSX:T) stock might have a huge dividend, but other names have more tailwinds and upside momentum.
Via The Motley Fool · July 10, 2026